We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

104 hedge funds and large institutions have $155M invested in ImmunityBio in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more capital invested

Capital invested by funds: $70.4M → $155M (+$85M)

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

39% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 23

9% more funds holding

Funds holding: 95 → 104 (+9)

1.31% more ownership

Funds ownership: 9.43% → 10.75% (+1.3%)

59% less call options, than puts

Call options by funds: $9.93M | Put options by funds: $24.1M

Holders
104
Holders Change
+9
Holders Change %
+9.47%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
32
Reduced
23
Closed
21
Calls
$9.93M
Puts
$24.1M
Net Calls
-$14.1M
Net Calls Change
-$12M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$11.5M
2
Invesco
Invesco
Georgia
+$3.31M
3
JP Morgan Chase
JP Morgan Chase
New York
+$2.97M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.55M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$4.28M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.98M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.94M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$977K
5
SSA
Schonfeld Strategic Advisors
New York
-$873K
Name Holding Trade Value Shares
Change 		Change in
Stake
KTC
101
Kistler-Tiffany Companies
Pennsylvania
$1K – – –
IA
102
Inspire Advisors
Idaho
$1K +$606 +63 New
AIG
103
American International Group
New York
$244 -$5.05K -525 -3%
Two Sigma Investments
104
Two Sigma Investments
New York
– -$4.28M -617,599 Closed
Two Sigma Advisers
105
Two Sigma Advisers
New York
– -$2.98M -429,233 Closed
Citadel Advisors
106
Citadel Advisors
Florida
– -$2.94M -306,067 Closed
SSA
107
Schonfeld Strategic Advisors
New York
– -$873K -125,800 Closed
Qube Research & Technologies (QRT)
108
Qube Research & Technologies (QRT)
United Kingdom
– -$385K -55,479 Closed
PP
109
PDT Partners
New York
– -$311K -44,814 Closed
JF
110
Jump Financial
Illinois
– -$309K -44,500 Closed
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
– -$296K -42,661 Closed
Millennium Management
112
Millennium Management
New York
– -$276 -39,865 Closed
Squarepoint
113
Squarepoint
New York
– -$267K -38,571 Closed
MFS
114
Mirabella Financial Services
United Kingdom
– -$159K -22,902 Closed
OMC
115
Old Mission Capital
Illinois
– -$149K -21,500 Closed
CSS
116
Cubist Systematic Strategies
Connecticut
– -$132K -18,974 Closed
E
117
Ergoteles
New York
– -$114K -16,374 Closed
BCM
118
Bridgeway Capital Management
Texas
– -$92K -13,300 Closed
ECM
119
ExodusPoint Capital Management
New York
– -$82K -11,892 Closed
JCM
120
JS Capital Management
New York
– -$80K -11,600 Closed
MAM
121
Meeder Asset Management
Ohio
– -$54K -7,782 Closed
SO
122
STRS Ohio
Ohio
– -$52K -7,500 Closed
PHK
123
Point72 Hong Kong
Hong Kong
– -$48K -6,987 Closed
TPWA
124
TRUE Private Wealth Advisors
Oregon
– -$3K -500 Closed
BWM
125
BerganKDV Wealth Management
Minnesota
– +$327 +34 New
1 2 3 4
5

IBRX Hedge Fund Activity: Q4 2020 in Review

104 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q4 2020, worth a combined $155M — up 121% from $70.4M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IBRX positions and 21 closed out — a net gain of 10 holders — while 32 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $11.5M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $4.28M sold.

  • 104 institutional investors held ImmunityBio (IBRX) as of Q4 2020, up from 95 in Q3 2020.
  • Funds reported $155M of ImmunityBio stock for Q4 2020, up 121% quarter-over-quarter.
  • 31 funds opened new ImmunityBio positions in Q4 2020 and 21 closed out, a net change of +10 holders.
  • The largest ImmunityBio buyer in Q4 2020 was BlackRock, an estimated $11.5M added.
  • The largest ImmunityBio seller in Q4 2020 was Two Sigma Investments, an estimated $4.28M sold.

Based on aggregated 13F filings for Q4 2020.